TY - JOUR AU - Noro, Rintaro AU - Yamada, Tesshi PY - 2012 TI - Drifting EGFR mutation JF - Chinese Clinical Oncology; Vol 2, No 1 (March 10, 2013): Chinese Clinical Oncology Y2 - 2012 KW - N2 - It is generally accepted that somatic mutation in the EGFR gene can serve as a biomarker for predicting the efficacy of treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) in patients with non-small cell lung cancer (NSCLC). UR - https://cco.amegroups.org/article/view/1265